Giulio Draetta, former MD Anderson CSO, center director joins privately held Orionis Biosciences

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Giulio Draetta was recently named chief strategy officer at Orionis Biosciences, a privately held, clinical stage life sciences company focused on discovery, design, and development of precision medicines for cancer and immune system-related disorders. Orionis is based in Boston and Ghent, Belgium.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login